0000929638-26-001870.txt : 20260515
0000929638-26-001870.hdr.sgml : 20260515
20260515124535
ACCESSION NUMBER: 0000929638-26-001870
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering
FILED AS OF DATE: 20260515
DATE AS OF CHANGE: 20260515
EFFECTIVENESS DATE: 20260515
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Trellis Bioscience, Inc.
CENTRAL INDEX KEY: 0001162015
ORGANIZATION NAME:
EIN: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-584215
FILM NUMBER: 26984982
BUSINESS ADDRESS:
STREET 1: 1505-B O'BRIEN DRIVE
CITY: MENLO PARK
STATE: CA
ZIP: 94025
BUSINESS PHONE: 650-616-1100
MAIL ADDRESS:
STREET 1: 1505-B O'BRIEN DRIVE
CITY: MENLO PARK
STATE: CA
ZIP: 94025
FORMER COMPANY:
FORMER CONFORMED NAME: TRELLIS BIOSCIENCE LLC
DATE OF NAME CHANGE: 20111108
FORMER COMPANY:
FORMER CONFORMED NAME: TRELLIS BIOSCIENCE INC
DATE OF NAME CHANGE: 20011108
D
1
primary_doc.xml
X0708
D
LIVE
0001162015
Trellis Bioscience, Inc.
702 Marshall Street
Suite 301
Redwood City
CA
CALIFORNIA
94063
408-772-8049
DELAWARE
None
TRELLIS BIOSCIENCE LLC
TRELLIS BIOSCIENCE INC
Corporation
true
Stefan
Ryser
702 Marshall Street
Suite 301
Redwood City
CA
CALIFORNIA
94063
Executive Officer
President and Chief Executive Officer
Elisabeth
Whitney
702 Marshall Street
Suite 301
Redwood City
CA
CALIFORNIA
94063
Executive Officer
Chief Operating Officer
Nora
Mende
702 Marshall Street
Suite 301
Redwood City
CA
CALIFORNIA
94063
Executive Officer
Chief Financial Officer
Larry
Kauvar
702 Marshall Street
Suite 301
Redwood City
CA
CALIFORNIA
94063
Executive Officer
Chief Science Officer
Geoff
Dillon
702 Marshall Street
Suite 301
Redwood City
CA
CALIFORNIA
94063
Executive Officer
Chief Business Officer
Biotechnology
Decline to Disclose
- 06b
false
2026-01-30
false
true
true
Series C Interests
false
0
Indefinite
6093000
Indefinite
false
16
0
0
0
false
Trellis Bioscience, Inc.
Stefan Ryser
Stefan Ryser
President and Chief Executive Officer
2026-05-14